EDC for Longevity Clinical Trials

EDC for longevity clinical trials: aging and longevity endpoints, ePRO, and 21 CFR Part 11–aligned controls.

21 CFR Part 11–aligned · HIPAA-aligned security · No credit card required

Overview

EDC for Longevity Clinical Trials

Longevity clinical trials study interventions aimed at aging, healthspan, and related biomarkers and outcomes. Your EDC must support consent, CRFs, optional ePRO and patient-reported outcomes, biomarker and lab data, and full auditability for regulatory and publication use. Capture provides EDC, eConsent, ePRO, and safety in one platform with 21 CFR Part 11–aligned controls and HIPAA-aligned infrastructure, so longevity study teams can capture clinical and PRO data with one audit trail.

Why longevity trials need the right EDC

Longevity studies often combine biomarkers, functional assessments, and patient-reported outcomes. You need one system that handles consent, CRFs, and ePRO with the same audit trail and access controls. Legacy EDC may lack flexibility for emerging longevity endpoints. Capture is built for flexible study designs with controls aligned with 21 CFR Part 11 and HIPAA-aligned security.

Common longevity trial workflow

  • Protocol and consent; ethics and regulatory approvals
  • Site activation and enrollment
  • Baseline and follow-up; biomarker, functional, and PRO data
  • Safety and AE capture
  • Data review and query resolution
  • Database lock and export for analysis and regulatory use

Traditional tool pain points

  • EDC built for traditional therapeutic areas, not longevity endpoints
  • Separate ePRO and EDC systems; no single audit trail
  • High cost and long implementation for emerging study designs
  • Limited flexibility for biomarker and PRO combinations

How Capture supports longevity trials

  • Unified EDC with eConsent and ePRO; flexible forms for biomarkers and PRO
  • One platform and one audit trail for all data
  • 21 CFR Part 11–aligned controls and HIPAA-aligned security
  • Export for analysis and regulatory use; documentation for validation (Enterprise)

FAQ

Questions we hear a lot

Is Capture suitable for longevity clinical trials?
Yes. Capture supports longevity studies with flexible EDC, eConsent, and ePRO. You get 21 CFR Part 11–aligned controls and one audit trail for clinical and PRO data.
Can we capture biomarker and PRO data?
Yes. You can design forms for biomarkers, lab data, and patient-reported outcomes. ePRO can support questionnaires and diaries. All data is captured with full audit history.
What about compliance?
Capture is designed with 21 CFR Part 11–aligned controls and HIPAA-aligned security. We provide documentation to support sponsor validation when required (Enterprise).

Ready to see Capture in action?

Explore the platform with a free sandbox. No sales call required.